Have your own idea? Try our Stock Screener
Australian (ASX) Pharma Industry Analysis
UpdatedOct 04, 2025
DataAggregated Company Financials
Companies26
- 7D16.0%
- 3M32.4%
- 1Y-7.7%
- YTD19.0%
Over the last 7 days, the Pharma industry has risen 16%, driven by gains from Clarity Pharmaceuticals of 33%. During this same period, the Cann Group underperformed, falling 26%. However, the industry is down 7.7% over the past year. Earnings are forecast to grow by 29% annually.
Industry Valuation and Performance
Has the Australian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 04 Oct 2025 | AU$6.6b | AU$1.0b | -AU$202,211,775.00 | 14.6x | -32.8x | 6.6x |
| Mon, 01 Sep 2025 | AU$5.4b | AU$1.0b | -AU$239,102,912.00 | 13.9x | -22.5x | 5.3x |
| Wed, 30 Jul 2025 | AU$5.5b | AU$1.0b | -AU$210,394,927.00 | 14.8x | -26.3x | 5.4x |
| Fri, 27 Jun 2025 | AU$4.4b | AU$1.1b | -AU$225,511,927.00 | 14.9x | -19.7x | 4.2x |
| Sun, 25 May 2025 | AU$4.4b | AU$1.0b | -AU$238,266,485.00 | 17.6x | -18.4x | 4.2x |
| Tue, 22 Apr 2025 | AU$4.2b | AU$1.0b | -AU$238,266,485.00 | 17.5x | -17.5x | 4x |
| Thu, 20 Mar 2025 | AU$4.8b | AU$1.1b | -AU$289,508,485.00 | 18.8x | -16.7x | 4.5x |
| Sat, 15 Feb 2025 | AU$5.3b | AU$1.0b | -AU$377,002,613.00 | 14.2x | -14.1x | 5.2x |
| Mon, 13 Jan 2025 | AU$5.2b | AU$1.0b | -AU$378,981,112.00 | 12.2x | -13.7x | 5.1x |
| Wed, 11 Dec 2024 | AU$5.8b | AU$1.0b | -AU$378,981,112.00 | 12.9x | -15.2x | 5.7x |
| Fri, 08 Nov 2024 | AU$6.3b | AU$1.0b | -AU$377,703,112.00 | 14.1x | -16.8x | 6.2x |
| Sun, 06 Oct 2024 | AU$6.6b | AU$1.0b | -AU$377,703,112.00 | 12.9x | -17.5x | 6.5x |
| Tue, 03 Sep 2024 | AU$6.7b | AU$1.0b | -AU$383,620,117.00 | 13.4x | -17.4x | 6.6x |
| Thu, 01 Aug 2024 | AU$6.7b | AU$995.3m | -AU$387,920,108.00 | 11x | -17.2x | 6.7x |
| Sat, 29 Jun 2024 | AU$6.5b | AU$995.3m | -AU$387,920,108.00 | 11.5x | -16.7x | 6.5x |
| Mon, 27 May 2024 | AU$6.3b | AU$1.2b | -AU$374,923,684.00 | 14.4x | -16.7x | 5.1x |
| Wed, 24 Apr 2024 | AU$5.5b | AU$1.2b | -AU$374,923,684.00 | 13.5x | -14.7x | 4.5x |
| Fri, 22 Mar 2024 | AU$5.7b | AU$1.2b | -AU$374,923,684.00 | 14.7x | -15.3x | 4.7x |
| Sun, 18 Feb 2024 | AU$5.3b | AU$892.3m | -AU$534,729,129.00 | 20.4x | -9.9x | 5.9x |
| Tue, 16 Jan 2024 | AU$5.7b | AU$896.3m | -AU$589,604,392.00 | 21.4x | -9.7x | 6.4x |
| Thu, 14 Dec 2023 | AU$4.5b | AU$896.3m | -AU$589,604,392.00 | 16.6x | -7.7x | 5.1x |
| Sat, 11 Nov 2023 | AU$4.0b | AU$893.0m | -AU$595,020,018.00 | 18.1x | -6.7x | 4.5x |
| Mon, 09 Oct 2023 | AU$3.6b | AU$900.3m | -AU$587,952,018.00 | 19x | -6.1x | 4x |
| Wed, 06 Sep 2023 | AU$3.7b | AU$900.3m | -AU$587,952,018.00 | 19.6x | -6.3x | 4.1x |
| Fri, 04 Aug 2023 | AU$4.1b | AU$999.0m | -AU$624,794,303.00 | 21.5x | -6.5x | 4.1x |
| Sun, 02 Jul 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 22.7x | -6.3x | 4x |
| Tue, 30 May 2023 | AU$4.0b | AU$993.2m | -AU$640,306,659.00 | 18.5x | -6.3x | 4.1x |
| Thu, 27 Apr 2023 | AU$4.2b | AU$993.2m | -AU$641,969,868.00 | 18.5x | -6.6x | 4.3x |
| Sat, 25 Mar 2023 | AU$4.0b | AU$995.9m | -AU$648,651,745.00 | 18.2x | -6.2x | 4.1x |
| Mon, 20 Feb 2023 | AU$3.6b | AU$980.5m | -AU$583,404,566.00 | 16.6x | -6.2x | 3.7x |
| Wed, 18 Jan 2023 | AU$11.6b | AU$948.3m | -AU$544,428,006.00 | 12.9x | -21.3x | 12.2x |
| Fri, 16 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,006.00 | 13.5x | -7.2x | 4.1x |
| Sun, 13 Nov 2022 | AU$4.3b | AU$948.3m | -AU$544,428,005.00 | 12.7x | -8x | 4.6x |
| Tue, 11 Oct 2022 | AU$4.2b | AU$946.2m | -AU$548,400,005.00 | 12.4x | -7.7x | 4.5x |
Price to Earnings Ratio
-7.7x
Current Industry PE
- Investors are optimistic on the Australian Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.9x is lower than the industry's current PS ratio of 6.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Australian Healthcare industry?
| AU Market | 2.33% | |
| Healthcare | 4.84% | |
| Pharma | 16.04% | |
| Pharma | 16.04% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CU6 Clarity Pharmaceuticals | AU$5.01 | 33.2% +AU$464.9m | -34.7% | PS196.9x | |
| NEU Neuren Pharmaceuticals | AU$21.50 | 10.9% +AU$266.5m | 53.0% | PE18.2x | |
| SPL Starpharma Holdings | AU$0.34 | 54.5% +AU$50.2m | 250.5% | PS24.3x | |
| MYX Mayne Pharma Group | AU$5.77 | 11.8% +AU$49.6m | 28.2% | PS1.1x | |
| BOT Botanix Pharmaceuticals | AU$0.17 | 6.5% +AU$19.6m | -55.4% | PS55.9x |